H.C. Wainwright reiterated its Buy rating on OKYO Pharma Ltd. (NASDAQ: OKYO) with a price target of $7.00, representing significant upside potential from the current trading price of $1.10. According ...
Prior Scientific has introduced new variants of the H117 motorized stages that are specifically designed for Evident ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback